Showing results (21-30 of 42) with videos related to
Sort By:
Pageof 5
Frontiers in Pharmacology|March 7, 2024
Lung cancer, comorbidities, and medication: the infernal trioHélène Pluchart, Sébastien Chanoine, Denis Moro-Sibilot, et al.Expert Opinion on Pharmacotherapy|March 12, 2013
PROFILing non-small-cell lung cancer patients for treatment with crizotinib according to anaplastic lymphoma kinase abnormalities: translating science into medicineSara Pilotto, Umberto Peretti, Silvia Novello, et al.Therapeutic Advances in Medical Oncology|January 6, 2021
Nivolumab treatment in advanced non-small cell lung cancer: real-world long-term outcomes within overall and special populations (the UNIVOC study)Jean-Baptiste Assié, Romain Corre, Matteo Giaj Levra, et al.Respiratory Medicine and Research|July 9, 2021
Identification of a predictive metabolic signature of response to immune checkpoint inhibitors in non-small cell lung cancer: METABO-ICI clinical study protocolSarah Sannicolo, Matteo Giaj Levra, Audrey Le Gouellec, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
Polymerase eta mRNA expression predicts survival of non-small cell lung cancer patients treated with platinum-based chemotherapyPaolo Ceppi, Silvia Novello, Alberto Cambieri, et al.BMC Cancer|January 6, 2021
Factors associated with survival of patients with solid Cancer alive after intensive care unit discharge between 2005 and 2013Hubert Gheerbrant, Jean-François Timsit, Nicolas Terzi, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 14, 2019
Defining Synchronous Oligometastatic Non-Small Cell Lung Cancer: A Systematic ReviewNiccolò Giaj-Levra, Matteo Giaj-Levra, Valerie Durieux, et al.JCO Clinical Cancer Informatics|February 3, 2022
Machine Learning-Based Analysis of Treatment Sequences Typology in Advanced Non-Small-Cell Lung Cancer Long-Term Survivors Treated With NivolumabChristos Chouaïd, Valentine Grumberg, Alexandre Batisse, et al.The Annals of Thoracic Surgery|February 6, 2018
Operation and Chemotherapy: Prognostic Factors for Lung Cancer With One Synchronous MetastasisAnne-Claire Toffart, Michaël Duruisseaux, Pierre-Yves Brichon, et al.Lung Cancer (Amsterdam, Netherlands)|January 9, 2020
Immunotherapy rechallenge after nivolumab treatment in advanced non-small cell lung cancer in the real-world setting: A national data base analysisMatteo Giaj Levra, François-Emery Cotté, Romain Corre, et al.Pageof 5